The Role of IL-23 in Patients with Idiopathic Thrombocytopenic Purpura

Document Type : Original Article


1 Department of clinical and chemical pathology, Sohag Faculty of Medicine, Sohag University.

2 Department of Clinical and Pathology,sohag faculty of medicine,sohag university

3 Department of Clinical and Chemicl Pathology, Sohag Faculty of Medicine, Sohag University

4 Department of clinical and chemical pathology, Sohag Faculty of Medicine


Idiopathic thrombocytopenic purpura (ITP)is a bleeding disorder with an unclear etiology ,The most common hemorrhagic autoimmune disease, and characterized by isolated thrombocytopenia that is not accompanied by any other disorders that may lead to thrombocytopenia. Interleukin-23 (IL-23) is a member of the IL-12 family; it is primarily secreted by activated dendritic cells, Monocytes, and macrophages and has important implication in the pathogenesis of many autoimmune diseases. The aims of this study was to evaluate the role of IL-23 in diagnosis of idiopathic thrombocytopenic purpura. A total of 5 papers were obtained using the mentioned keywords in the research of all internet-based databases.  The total number of cases in all of the studies was 239 cases. The mean age was recorded in 5 papers, and the mean age of each of them was 32.8 years.   There are different method of detection of IL23 in different studies such as PCR, ELISA and flow cytometry These findings suggest that levels of IL-23 are significantly higher in ITP patients.


  1. F1. ransen K, van Sommeren S, Westra HJ, Veenstra M, Lamberts LE, et al. (2014) Correlation of genetic risk and messenger RNA expression in a Th17/IL23 pathway analysis in inflammatory bowel disease.Inflamm Bowel Dis 20: 777–782. Doi:10.1097

2. Gee K, Guzzo C, Che Mat NF, Ma W, Kumar A (2009) The IL-12 family of cytokines in infection, inflammation and autoimmune disorders. Inflamm Allergy Drug Targets 8: 40–52. PMID: 19275692

3.Hala M. Farawela, Shahira K.A. Botros, Mona El-Ghamrawy and Eman O. Ebrahim,(2015) Blood Coagulation and Fibrinolysis 2016, 27:374–377.

4. Lubberts E (2008) IL-17/Th17 targeting: on the road to prevent chronic destructive arthritis Cytokine 41: 84–91. PMID: 18039580

5.Neunert CE (2013):Current management of immune thrombocytopenia. ASH Education book,2013(1) 276-282.

6.Oppmann B, Lesley R, Blom B, et al(2009): Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. Immunity ;13:715–25



7.Qian C, Jiang T, Zhang W, Ren C, Wang Q, et al. (2013) Increased IL-23 and IL-17 expression by peripheral blood cells of patients with  primary biliary cirrhosis. Cytokine 64: 172–180. doi: 10.1016/j.cyto.2013.07.005 PMID: 23910013

8.Qingsheng Li a Linjie Zhang b Ruixiang Xia a Qingshu Zeng a Yongqing Wang a Liang Xia a Leiming Xia a Mingzhen Yang(2014)  Med Princ Pract DOI: 10.1159/000433472.

9.Qingsheng Li, Mingzhen Yang , Ruixiang Xia, Leiming Xia, & Linjie Zhang (2014 )Informa UK Ltd. DOI: 10.3109/09537104.2014.934217

10.Semple JW, Provan D (2012) The immunopathogenesis of immune  thrombocytopenia: T cells still takecenter-stage. Curr Opin Hematol 19: 357–362. doi:10.1097/MOH.0b013e3283567541PMID:22759631.

11.Semple JW, Provan D, Garvey MB, Freedman J (2010) Recent progress in understanding the pathogenesisof immune thrombocytopenia. Curr Opin Hematol 17: 590–595. doi:10.1097/MOH.0b013e32833eaef3 PMID: 20739879

12.Suzuki E, Mellins ED, Gershwin ME, et al (2014):  The IL-23/IL-17 axis in psoriatic arthritis. Autoimmun Rev;13(4-5):496-502,

13.Yanxia Zhan & Fanli Hua & Lili Ji & Weiguang Wang &Shanhua Zou & Xiaoyun Wang & Feng Li &Yunfeng Cheng Ann Hematol (2013)  92:1057–1062 DOI 10.1007/s00277-013-1731-3.

14.Ye X, Zhang L, Wang H, Chen Y, Zhang W,Zhu R, et al. (2015) The Role of IL-23/Th17 Pathway in Patients with Primary Immune Thrombocytopenia. PLoS ONE 10(1): e0117704. doi:10.1371/journal.pone.0117704